Search Results
Results found for "opioid pharmacology"
- Dr. Josephine (Pina) Cardarelli | Dr. GPCR Ecosystem
She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology Previously, she held the position of Vice President of Cell Biology & Pharmacology, at Bristol-Myers
- Dr. Gregory Tall | Dr. GPCR Ecosystem
Tall joined the faculty in the Department of Pharmacology and Physiology at the University of Rochester Tall moved to the University of Michigan in 2016 as an Associate Professor of Pharmacology and is a current
- Dr. Antony A. Boucard Jr | Dr. GPCR Ecosystem
Gaetan Guillemette in the Pharmacology department at the Université de Sherbrooke. The pharmacology of latrophilins brings about a great deal of challenges given that they are highly polymorphic
- You never know where your GPCR takes you with Dr. Brian Hudson | Dr. GPCR Ecosystem
He leads a research group that is focused on understanding the pharmacology and function of a group a
- Dr. Nicolas Gilles | Dr. GPCR Ecosystem
When the pharmacological properties of these new ligands are deemed exceptional, a lead optimization
- Yao Lu (Jackie) | Dr. GPCR Ecosystem
Her work involves the pharmacological and structural characterisation of novel putative antipsychotic
- ep 175 with jens carlsson clip 1 | Dr. GPCR Ecosystem
This kind of predictive modeling challenges the traditional role of computation in pharmacology, where That scientific humility (combined with deep collaborations with medicinal chemists and pharmacologists This episode is essential listening for anyone thinking seriously about translational pharmacology and Yet, any pharmacologist who’s pushed beyond textbook theory knows: biology rarely plays fair. GPCR Podcast 4 days ago Molecular creativity in drug discovery Most pharmacologists are trained to chase
- Dr. Oliver Hartley | Dr. GPCR Ecosystem
then Oliver has worked at the University of Geneva, where his research on peptide engineering and GPCR pharmacology
- Dr. Steven Foord | Dr. GPCR Ecosystem
Steven Foord Steve Foord trained as a Physiologist and Pharmacologist and worked for Glaxo through to He introduced molecular pharmacology to a wide range of the company's GPCR projects and was able to initiate
- Dr. Qing Fan | Dr. GPCR Ecosystem
Fan is currently an associate professor of Pharmacology and Pathology and Cell Biology at Columbia University
- Empowering Drug Discovery for the GPCR Community with Dr. Justin English | Dr. GPCR Ecosystem
His lab focuses on developing and innovating technologies to solve broad questions in pharmacology, with
- Dr. Terry Hébert | Dr. GPCR Ecosystem
Terry Hébert is a Professor within the Department of Pharmacology & Therapeutics at McGill University
- From Pipettes to Platforms The Evolution of GPCR Research | Dr. GPCR Ecosystem
and insights: https://www.ecosystem.drgpcr.com/gpcr-university-pricing #GPCR #DrGPCR #DrugDiscovery #Pharmacology
- CRO Advisory | Dr. GPCR Ecosystem
Any CRO focused on GPCRs, pharmacology, discovery biology, or antibody discovery—regardless of size or Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- VC Insights | Dr. GPCR Ecosystem
contingency-ready paths " Yamina brings scientific clarity, leadership, and precision execution to complex pharmacological Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies
Gutkind is a Distinguished Professor and Chair of the Department of Pharmacology, School of Medicine,
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
using innovative approaches, including biosensors, cryo-EM, photoswitchable ligands, and nanobodies as pharmacological
- Dr. Maria Waldhoer | Dr. GPCR Ecosystem
She earned her M.Sc. in Zoology and Neurobiology before completing a Ph.D. in Biology and Pharmacology
- Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease
In April 2009, he joined the Department of Pharmacology and Toxicology at University of Toronto and has
- ep 175 with jens carlsson clip 2 | Dr. GPCR Ecosystem
They collaborate deeply with medicinal chemists, pharmacologists, and biotech partners to create workflows GPCR Podcast: model predict discover #DrGPCR #GPCR #CollaborationInScience #ComputationalChemistry #Pharmacology
- ep 175 with jens carlsson clip 3 | Dr. GPCR Ecosystem
screening compounds, or designing next-gen molecules, this insight reframes what “success” in computational pharmacology
- 🔥 New Course Alert! “Development of GPCR Ligands as Therapeutic Drugs” with Dr. Terry Kenakin is here! Spots are filling up fast—Premium Members get 25% off! This advanced course is exclusively available in the Ecosystem, so don’t miss your chance to learn from the best. 🔹 Secure your spot now! 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy #drugdiscovery #research | Dr. GPCR Ecosystem
www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy
- Dr. GPCR Board | Dr. GPCR Ecosystem
Maria Waldhoer "I am a pharmacologist with a ~30 years background in academia and industry, working both Trejo joined the faculty in the Department of Pharmacology at the University of North Carolina in 2000 and then moved to UC San Diego School Medicine, Department of Pharmacology in 2008, where she quickly In 2014, she was appointed Vice-Chair of the Department of Pharmacology. The long-term goal of Dr.
- Celtarys Research | Dr. GPCR Ecosystem
in a competitive manner and in a short time (<3 months), customized fluorescent ligands with optimal pharmacological Chemistry and Technology from the University of Bari and completed her PhD in Biomolecular Sciences in Pharmacology Probes Innovative fluorescent probes that de-risk the pre-clinical drug discovery phase with optimal pharmacological
- irreversible drugs post 2 | Dr. GPCR Ecosystem
www.ecosystem.drgpcr.com/post/beyond-clearance-the-strategic-power-of-irreversible-drug-binding #GPCR #DrGPCR #Pharmacology
- Dr. Antonella Di Pizio | Dr. GPCR Ecosystem
Join us to learn more about chemosensory GPCRs and how computational pharmacology can help better understand
- Dr. Kari Johnson | Dr. GPCR Ecosystem
Kari completed her Ph.D. in Pharmacology at Vanderbilt University before continuing her training as a
- Dr. Juan José Fung | Dr. GPCR Ecosystem
mainly focused on screening and assay development to bridge the gap between in vitro and in vivo GPCR pharmacology
- Dr. Ross Cheloha | Dr. GPCR Ecosystem
Work in his independent laboratory is focused on developing new pharmacological tools via chemistry and
- Dr. Daniel Isom | Dr. GPCR Ecosystem
Isom was recruited to the Molecular and Cellular Pharmacology Department at the University of Miami Miller School of Medicine in 2016, where he is currently a practicing molecular pharmacologist and biophysicist























